ProQR Therapeutics N.V. SEC filings and other documents
Description
Event date
Documents and forms
2025
Q2 2025
Aug 7, 2025
Earnings release8-K
Q1 2025
May 7, 2025
Earnings release8-K
2024
Q4 2024
Mar 13, 2025
Press release
Annual report20-F
Q3 2024
Nov 7, 2024
Earnings release8-K
Q2 2024
Aug 8, 2024
Earnings release8-K
Status Update
May 9, 2024
Press release
Slides
Q1 2024
May 9, 2024
Earnings release8-K
2023
Q4 2023
Mar 13, 2024
Annual report20-F
Annual report20-F
Earnings release8-K
Q3 2023
Nov 7, 2023
Earnings release8-K
Q2 2023
Aug 3, 2023
Earnings release8-K
Q1 2023
May 16, 2023
Earnings release8-K
Investor Update
Mar 29, 2023
Press release
2022
Q4 2022
Mar 29, 2023
Annual report10-K
Investor Update
Dec 22, 2022
Slides
Q3 2022
Nov 9, 2022
Earnings release8-K
Investor Update
Aug 11, 2022
Press release
Q2 2022
Aug 4, 2022
Earnings release8-K
Q1 2022
May 5, 2022
Earnings release8-K
Strategy Update
Apr 13, 2022
Press release
Slides
Study Result
Feb 11, 2022
Press release
2021
Q4 2021
Feb 24, 2022
Annual report20-F
Annual report20-F
Earnings release8-K
Analyst Meeting
Nov 18, 2021
Slides
Q3 2021
Nov 4, 2021
Earnings release8-K
Investor Update
Sep 9, 2021
Slides
Q2 2021
Aug 5, 2021
Earnings release8-K
Q1 2021
May 6, 2021
Earnings release8-K
Study Result
Mar 24, 2021
Press release
Slides
2020
Q4 2020
Feb 25, 2021
Annual report20-F
Annual report20-F
Earnings release8-K
Q3 2020
Nov 16, 2020
Earnings release8-K
Q2 2020
Aug 6, 2020
Earnings release8-K
Q1 2020
May 7, 2020
Earnings release8-K
2019
Q4 2019
Feb 26, 2020
Earnings release8-K
Q3 2019
Nov 12, 2019
Earnings release8-K
Q2 2019
Aug 7, 2019
Earnings release8-K
Q1 2019
May 8, 2019
Earnings release8-K
2018
Q4 2018
Feb 27, 2019
Earnings release8-K
Q3 2018
Nov 7, 2018
Earnings release8-K
Q2 2018
Aug 8, 2018
Earnings release8-K
Q1 2018
May 10, 2018
Earnings release8-K